GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Telo Genomics Corp (FRA:3D0A) » Definitions » Cyclically Adjusted FCF per Share

Telo Genomics (FRA:3D0A) Cyclically Adjusted FCF per Share : €-0.13 (As of Mar. 2024)


View and export this data going back to 2016. Start your Free Trial

What is Telo Genomics Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Telo Genomics's adjusted free cash flow per share for the three months ended in Mar. 2024 was €-0.006. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is €-0.13 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

As of today (2024-06-13), Telo Genomics's current stock price is €0.0925. Telo Genomics's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was €-0.13. Telo Genomics's Cyclically Adjusted Price-to-FCF of today is .


Telo Genomics Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Telo Genomics's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Telo Genomics Cyclically Adjusted FCF per Share Chart

Telo Genomics Annual Data
Trend Dec13 Dec14 Dec15 Jun17 Jun18 Jun19 Jun20 Jun21 Jun22 Jun23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only - - - -0.17 -0.15

Telo Genomics Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.17 -0.15 -0.16 -0.13 -0.13

Competitive Comparison of Telo Genomics's Cyclically Adjusted FCF per Share

For the Diagnostics & Research subindustry, Telo Genomics's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Telo Genomics's Cyclically Adjusted Price-to-FCF Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Telo Genomics's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Telo Genomics's Cyclically Adjusted Price-to-FCF falls into.



Telo Genomics Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Telo Genomics's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.006/126.2576*126.2576
=-0.006

Current CPI (Mar. 2024) = 126.2576.

Telo Genomics Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.041 99.473 -0.052
201409 -0.009 99.394 -0.011
201412 -0.005 98.367 -0.006
201503 0.000 99.789 0.000
201506 -0.019 100.500 -0.024
201509 0.000 100.421 0.000
201512 -0.039 99.947 -0.049
201603 -0.029 101.054 -0.036
201606 -0.034 102.002 -0.042
201609 -0.367 101.765 -0.455
201612 -0.143 101.449 -0.178
201703 -0.101 102.634 -0.124
201706 -0.090 103.029 -0.110
201709 -0.054 103.345 -0.066
201712 -0.100 103.345 -0.122
201803 -0.135 105.004 -0.162
201806 -0.025 105.557 -0.030
201809 -0.003 105.636 -0.004
201812 -0.005 105.399 -0.006
201903 -0.003 106.979 -0.004
201906 -0.005 107.690 -0.006
201909 -0.009 107.611 -0.011
201912 0.000 107.769 0.000
202003 -0.007 107.927 -0.008
202006 -0.008 108.401 -0.009
202009 -0.003 108.164 -0.004
202012 -0.005 108.559 -0.006
202103 -0.004 110.298 -0.005
202106 -0.004 111.720 -0.005
202109 -0.004 112.905 -0.004
202112 -0.007 113.774 -0.008
202203 -0.005 117.646 -0.005
202206 -0.006 120.806 -0.006
202209 -0.007 120.648 -0.007
202212 -0.009 120.964 -0.009
202303 -0.008 122.702 -0.008
202306 -0.008 124.203 -0.008
202309 -0.007 125.230 -0.007
202312 -0.007 125.072 -0.007
202403 -0.006 126.258 -0.006

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Telo Genomics  (FRA:3D0A) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Telo Genomics Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Telo Genomics's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Telo Genomics (FRA:3D0A) Business Description

Traded in Other Exchanges
Address
101 College Street, Suite 200, MaRS Centre, South Tower, Toronto, ON, CAN, M5G 1L7
Telo Genomics Corp is a personalized medicine company. The company through its wholly-owned subsidiary is engaged in the development and commercialization of diagnostic and prognostic products. The company is developing diagnostic and prognostic products for cancer and neurological disorders.

Telo Genomics (FRA:3D0A) Headlines

No Headlines